Roche to buy US Biotech Firm InterMune for $8.3 Billion

25.08.2014 - Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. The...